These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7513408)

  • 1. Why do some patients have high defibrillation thresholds at defibrillator implantation? Answers from basic research.
    Hillsley RE; Wharton JM; Cates AW; Wolf PD; Ideker RE
    Pacing Clin Electrophysiol; 1994 Feb; 17(2):222-39. PubMed ID: 7513408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac potential and potential gradient fields generated by single, combined, and sequential shocks during ventricular defibrillation.
    Wharton JM; Wolf PD; Smith WM; Chen PS; Frazier DW; Yabe S; Danieley N; Ideker RE
    Circulation; 1992 Apr; 85(4):1510-23. PubMed ID: 1555291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Energy levels for defibrillation: what is of real clinical importance?
    Fotuhi PC; Epstein AE; Ideker RE
    Am J Cardiol; 1999 Mar; 83(5B):24D-33D. PubMed ID: 10089836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful implantation of cardioverter-defibrillator systems in patients with elevated defibrillation thresholds.
    Brooks R; Torchiana D; Vlahakes GJ; Ruskin JN; McGovern BA; Garan H
    J Am Coll Cardiol; 1993 Aug; 22(2):569-74. PubMed ID: 8335831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracardiac atrial defibrillation.
    Dosdall DJ; Ideker RE
    Heart Rhythm; 2007 Mar; 4(3 Suppl):S51-6. PubMed ID: 17336885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.
    Maagh P; Trappe HJ; Meissner A
    Europace; 2007 Dec; 9(12):1161-2. PubMed ID: 17913694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of a defibrillation electrode in the low right atrium to a right ventricular lead does not reduce ventricular defibrillation thresholds.
    Rüb N; Schweitzer O; Mewis C; Kettering K; Kuehlkamp V
    Pacing Clin Electrophysiol; 2004 Mar; 27(3):346-51. PubMed ID: 15009861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of biphasic waveform pulse on endocardial defibrillation efficacy in humans.
    Neuzner J; Pitschner HF; Huth C; Schlepper M
    Pacing Clin Electrophysiol; 1994 Feb; 17(2):207-12. PubMed ID: 7513406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter-defibrillators.
    Swerdlow CD; Ahern T; Kass RM; Davie S; Mandel WJ; Chen PS
    J Am Coll Cardiol; 1996 Apr; 27(5):1112-8. PubMed ID: 8609329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transvenous biventricular defibrillation.
    Meisel E; Butter C; Philippon F; Higgins S; Strickberger SA; Smith J; Hahn S; Michel U; Schubert B; Pfeiffer D
    Am J Cardiol; 2000 Nov; 86(9A):76K-85K. PubMed ID: 11084104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defibrillation electrode configurations developed from cardiac mapping that combine biphasic shocks with sequential timing.
    Guse PA; Walcott GP; Rollins DL; Smith WM; Ideker RE
    Am Heart J; 1992 Dec; 124(6):1491-500. PubMed ID: 1462904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transvenous subcutaneous implantation technique of the cardioverter/defibrillator].
    Block M; Hammel D; Borggrefe M; Scheld HH; Breithardt G
    Herz; 1994 Oct; 19(5):259-77. PubMed ID: 8001899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impedance to defibrillation countershock: does an optimal impedance exist?
    KenKnight BH; Eyüboğlu BM; Ideker RE
    Pacing Clin Electrophysiol; 1995 Nov; 18(11):2068-87. PubMed ID: 8552522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oral propafenone on defibrillation and pacing thresholds in patients receiving implantable cardioverter-defibrillators. Propafenone Defibrillation Threshold Investigators.
    Stevens SK; Haffajee CI; Naccarelli GV; Schwartz KM; Luceri RM; Packer DL; Rubin AM; Kowey PR
    J Am Coll Cardiol; 1996 Aug; 28(2):418-22. PubMed ID: 8800119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An appropriate defibrillation threshold obtained by the combined connection between two shock leads and ICD generator.
    Sato A; Chinushi M; Iijima K; Watanabe H; Izumi D; Furushima H; Sonoda K; Hasegawa K; Yagihara N; Aizawa Y
    Intern Med; 2011; 50(22):2815-8. PubMed ID: 22082895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-energy endocardial defibrillation using an axillary or a pectoral thoracic electrode location.
    Saksena S; DeGroot P; Krol RB; Raju R; Mathew P; Mehra R
    Circulation; 1993 Dec; 88(6):2655-60. PubMed ID: 8252676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of defibrillation testing at the time of implantable cardioverter-defibrillator insertion.
    Hadid C; Atienza F; Strasberg B; Arenal Á; Codner P; González-Torrecilla E; Datino T; Percal T; Almendral J; Ortiz M; Martins R; Martinez-Alzamora N; Fernandez Aviles F
    Cardiol J; 2015; 22(3):253-9. PubMed ID: 25179316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: an international multicenter study. PCD Investigator Group.
    J Am Coll Cardiol; 1994 Jun; 23(7):1521-30. PubMed ID: 8195508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.